About Arakis
Arakis is an emerging specialty pharmaceutical company, with a therapeutic focus in inflammatory diseases, oncology adjunctive therapy and pain.
Advertisement
Product portfolio of Arakis
News about Arakis
Here you will find Arakis Ltd
Last viewed contents
The spider with the bee venom - New perspectives for the search for active substances against cell-based diseases - Researchers decode the toxin arsenal of the most poisonous native spider species
Spirea Ltd - Harrogate, United Kingdom
LETI Pharma GmbH - Ismaning, Germany
Opening the door to affordable lab-grown beef, cow cells defy aging - A potential game-changer for creating sustainable, ethical meat without the environmental toll of traditional livestock farming
EMD Serono, Inc. - Rockland, USA
Insilico Medicine-led study combines quantum computing and generative AI for drug discovery - “Quantum computing is recognized as the next technology breakthrough which will make a great impact, and the pharmaceutical industry is believed to be among the first wave of industries benefiting from the advancement”
Being fit Protects Against Health Risks Caused by Stress at Work
WIKA strengthens management team with Axel Schwerdtfeger - Process Solutions company division under new leadership
F-star - Wien, Austria
Chemical pollution threatens biodiversity - Scientists say more environmental pollutants should be considered in species protection
CureVac and GSK Enter into Pandemic Preparedness Contract with German Government - Five-year contract enables production of up to 80 million vaccine doses at short notice in case of a public health emergency